Showing results 1 - 2 of 2
December 4, 2024, Paper: "uncertainty regarding which brand-name prescription drugs will have their prices negotiated by Medicare in 2025. This Viewpoint analyzes the process that…
November 27, 2024, Paper: "The sole orphan exemption will exclude billions of dollars of Medicare drug spending from price negotiation. The high level of global revenues achieved…